{"organizations": [], "uuid": "018f177ebd6d2aa19c613bb4cf4b2a799e8b0dad", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-hls-therapeutics-announces-normal/brief-hls-therapeutics-announces-normal-course-issuer-bid-idUSFWN1SG1MN", "country": "US", "domain_rank": 408, "title": "BRIEF-HLS Therapeutics Announces Normal Course Issuer Bid", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-10T00:13:00.000+03:00", "replies_count": 0, "uuid": "018f177ebd6d2aa19c613bb4cf4b2a799e8b0dad"}, "author": "", "url": "https://www.reuters.com/article/brief-hls-therapeutics-announces-normal/brief-hls-therapeutics-announces-normal-course-issuer-bid-idUSFWN1SG1MN", "ord_in_thread": 0, "title": "BRIEF-HLS Therapeutics Announces Normal Course Issuer Bid", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "hls therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 9 (Reuters) - HLS Therapeutics Inc:\n* HLS THERAPEUTICS ANNOUNCES NORMAL COURSE ISSUER BID * HLS THERAPEUTICS - PURSUANT TO NORMAL COURSE ISSUER BID, CO MAY PURCHASE FOR CANCELLATION UP TO AGGREGATE OF 1.4 MILLION OF ITS ISSUED & OUTSTANDING SHARES Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-05-10T00:13:00.000+03:00", "crawled": "2018-05-10T00:33:30.001+03:00", "highlightTitle": ""}